International Journal of Oral Biology

  • 제40권2호
  • /
  • Pages.63-69
  • /
  • 2015
  • /
  • 1226-7155(pISSN)
  • /
  • 2287-6618(eISSN)
대한구강생물학회 (The Korean Academy of Oral Biology)
권호 표지
DOI QR코드

DOI QR Code

Apoptotic Activity of Curcumin and EF-24 in HTB-41 Human Salivary Gland Epidermoid Carcinoma Cells

  • Kim, Ji-Won (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Lee, Seul Ah (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Go, Dae-San (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Park, Byung-Sun (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Kim, Su-Gwan (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Yu, Sun-Kyoung (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Oh, Ji-Su (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Kim, Chun Sung (Oral Biology Research Institute, Chosun University School of Dentistry) ;
  • Kim, Jeongsun (Department of Dental Hygiene, Gwangju Health University) ;
  • Park, Jong-Tae (Department of Oral Anatomy, Dankook University School of Dentistry) ;
  • Kim, Do Kyung (Oral Biology Research Institute, Chosun University School of Dentistry)
  • 투고 : 2015.03.22
  • 심사 : 2015.06.10
  • 발행 : 2015.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Curcumin (diferuloylmethane), a constituent of turmeric powder derived from the rhizome of Curcuma longa, has been shown to inhibit the growth of various types of cancer cells by regulating cell proliferation and apoptosis. However, a need exists to design more effective analogs because of curcumin's poor intestinal absorption. EF-24 (diphenyl difluoroketone), the monoketone analog of curcumin, has shown good efficacy in anticancer screens. However, the effects of curcumin and EF-24 on salivary gland epidermoid carcinoma cells are not clearly established. The main goal of this study was to investigate the effects of curcumin and EF-24 on cell growth and induction of apoptosis in human salivary gland epidermoid carcinoma cells. Our studies showed that curcumin and EF-24 inhibited the growth of HTB-41 cells in a dose- and time-dependent manner, and the potency of EF-24 was > 34-fold that of curcumin. Treatment with curcumin or EF-24 resulted in nuclear condensation and fragmentation in HTB-41 cells, whereas the control HTB-41 cell nuclei retained their normal regular and oval shape. Curcumin and EF-24 promoted proteolytic cleavages of procaspase-3/-7/-9, resulting in an increase in the amount of cleaved caspase-3/-7/-9 in the HTB-41 cells. Caspase-3 and -7 activities were detected in viable HTB-41 cells treated with curcumin or EF-24. These results suggest that the curcumin and EF-24 inhibit cell proliferation and induce apoptosis in HTB-41 human salivary gland epidermoid carcinoma cells, and that they may have potential properties as an anti-cancer drug therapy.

키워드

참고문헌

  1. Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8:229-240. doi: 10.1034/j.1601-0825.2002.02870.x.
  2. Ellis GL, Auclair PL, Gnepp DR. Surgical pathology of the salivary glands. In: Primary squamous cell carcinoma (Auclair PL and Ellis GL, eds.). Philadelphia, W. B. Saunders Company, 1991. pp. 369-378.
  3. Cheng YL, Lee SC, Lin SZ, Chang WL, Chen YL, Tsai NM, Liu YC, Tzao C, Yu DS, Harn HJ. Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Lett. 2005;222:183-193. doi:10.1016/j.canlet.2004.10.015.
  4. Park DI, Lee JH, Moon SK, Kim CH, Lee YT, Cheong J, Choi BT, Choi YH. Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiforum in human lung carcinama cells. Pharmacol Res. 2005;51:437-443. doi:10.1016/j.phrs.2004.11.003.
  5. Tan ML, Suaiman SF, Najimuddin N, Smian MR, Tengku Muhammad TS. Methanolic extract of Pereskia bleo (Kunth) DC. (Cactaceae) induces apoptosis in breast carcinama, T47-D cell line. J Ethnopharmacol. 2005;96:287-294. doi:10.1016/j.jep.2004.09.025.
  6. Hoshino T, Hara A, Inoue M, Honda J, Imai Y, Oizumi K, Yokoyama MM. Flow cytometric measurement of NK cell cytotoxicity. J Clin Lab Immunol. 1991;36:39-43.
  7. Tian Z, Chen S, Zhang Y, Huang M, Shi L, Huang F, Fong C, Yang M, Xiao P. The cytotoxicity of naturally occurring styryl lactones. Phytomedicine. 2006;13:181-186. doi:10.1016/j.phymed.2004.07.010.
  8. Smets LA. Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drug. 1994;5:3-9.
  9. Paschka AG, Butler R, Young CYF. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 1998;130:1-7. doi: 10.1016/S0304-3835(98)00084-6.
  10. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1308-1312. doi:10.1126/science.281.5381.1309.
  11. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776. doi: 10.1038/35037710.
  12. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 2001;11:526-534. doi: 10.1016/S0962-8924(01)02173-0.
  13. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res. 2000;256:42-49. odoi: 10.1006/excr.2000.4838.
  14. Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med. 2001;7:314-319. doi:10.1016/S1471-4914(01)02026-3.
  15. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 2001;20:7597-7609. https://doi.org/10.1038/sj.onc.1204997
  16. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr. 2002;34:37-46. doi: 10.1016/S0167-4943(01)00194-7.
  17. Banerjee M, Tripathi LM, Srivastava VM, Puri A, Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol. 2003;25:213-224. https://doi.org/10.1081/IPH-120020471
  18. Sahu RP, Batra1 S, Srivastava SK. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer. 2009;100:1425-1433. doi: 10.1038/sj.bjc.6605039.
  19. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol. 2007;73:1024-1032. doi: 10.1016/j.bcp.2006.12.010.
  20. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vene R, Dell''Eva R, Jochum M, Albini A, Pfeffer U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem. 2007;19:137-152. doi:10.1159/000099202.
  21. Hauser PJ, Han Z, Sindhwani P, Hurst RE. Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix. Anticancer Res. 2007;27: 737-740.
  22. Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 30-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol. 2007;30:905-918. doi: 10.3892/ijo.30.4.905.
  23. Wahl H, Tan L, Griffith K, Choi M, Liu JR. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol. 2007;105:104-112. doi:10.1016/j.ygyno.2006.10.050.
  24. Ammon HP, Wahl MA. Pharmacol Curcuma longa. Planta Med. 1991;57:1-7. doi: 10.1055/s-2006-960004.
  25. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol. 2008;75:787-809. doi: 10.1016/j.bcp.2007.08.016.
  26. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807-818. doi:10.1021/mp700113r.
  27. Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem. 2004;12:3871-3883. doi: 10.1016/j.bmc.2004.05.006.
  28. Adams BK, Cai J, Armstrong J, Herold M, Lu YJ, Sun A, Snyder JP, Liotta DC, Jones DP, Shoji M. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redoxdependent mechanism. Anticancer Drugs. 2005;16:263-275. https://doi.org/10.1097/00001813-200503000-00005
  29. Lee MH, Kim MM, Kook JK, Kim DK, Kim HR, Kim HJ, Kim CS. Ethanol extracts of Angelica decursiva induces apoptosis in human oral cancer cells. Int J Oral Biol. 2010;35:215-220.
  30. Shin WC, Kim CS, Kim HJ, Lee MH, Kim HR, Kim DK. Growth inhibition of human head and neck squamous cell carcinomas by Angelica decursiva extracts. Int J Oral Biol. 2010;35:153-158.
  31. Kim JY, Kim HS, Kang HS, Choi JS, Yokozawa T, Chung HY. Antioxidant potential of dimethyl lithospermate isolated from Salvia miltiorrhiza (red sage) against peroxynitrite. J Med Food. 2008;11:21-28. doi:10.1089/jmf.2007.040.
  32. Kim CS, Moon IS, Park JH, Shin WC, Chun HS, Lee SY, Kook JK, Kim HJ, Park JC, Endou H, Kanai Y, Lee BK, Kim DK. Inhibition of L-type amino acid transporter modulates the expression of cell cycle regulatory factors in KB oral cancer cells. Biol Pharm Bull. 2010;33:1117-1121. http://doi.org/10.1248/bpb.33.1117.
  33. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326:1-16. https://doi.org/10.1042/bj3260001
  34. Datta R, Kojima H, Yoshida K, Kufe D. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem. 1997;272:20317-20320. doi:10.1074/jbc.272.33.20317.
  35. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 1997;89: 175-184. doi: 10.1016/S0092-8674(00)80197-X.
  36. Hu W, Kavanagh JJ. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003;4:721-729. doi:10.1016/S1470-2045(03)01277-4.
  37. Christou L, Hatzimichael E, Chaidos A, Tsiara S, Bourantas KL. Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone. Eur J Haematol. 2001;67:51-53. doi: 10.1034/j.1600-0609.2001.067001051.x.
  38. Mukherjee AK, Basu S, Sarkar N, Ghosh AC. Advances in cancer therapy with plant based natural products. Curr Med Chem. 2001;8:1467-1486. doi: 10.2174/0929867013372094.
  39. Pezutto JM. Plant-derived anticancer agents. Biochem Pharmacol. 1997;53:121-133. doi:10.1016/S0006-2952(96)00654-5.
  40. van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett. 1997;114:195-202. doi: 10.1016/S0304-3835(97)04662-4.